TJP Labs Inc. obtains a Pharmaceutical Establishment License (PEL) from Health Canada | Your money

PICKERING, Ontario, July 19 12, 2022 (GLOBE NEWSWIRE) — TJP Labs Inc. (“TJP Labs”) is North America’s leading full-service contract manufacturer of next-generation products, focusing on modern oral nicotine pouches and nicotine solutions. oral administration for energy and nutraceutical products. After carrying out a thorough examination

regulatory evaluation and meeting all GMP requirements, Health Canada granted TJP Labs Inc. a Drug Establishment License (DEL).

Any company that intends to import, manufacture, package, label or distribute pharmaceutical drugs must obtain a Pharmaceutical Establishment License in accordance with Health Canada regulatory requirements. It is a comprehensive and rigorous process to gain LED approval, as a business must demonstrate that it meets strict quality control standards and procedures.

The Drug Establishment License aligns with TJP Labs’ future goal of offering drug manufacturing services. Additionally, it reinforces TJP’s globally recognized full-service contract manufacturing expertise in next-generation nicotine and nutraceuticals.

Speaking on the achievement, David Richmond-Peck, CEO of TJP Labs, said:

“We are extremely excited about the future possibilities that drug establishment licenses offer our global customers. We founded TJP Labs to promote harm reduction globally and develop appropriate products for the protection of public health. Passing the rigorous inspection process conducted by Health Canada is proof that the unparalleled quality of our premier manufacturing facility aligns with our company’s long-term goals.

This license, including our site license for natural health products, ISO 9001:2015, HACCP and cGMP certifications, is testament to TJP Labs’ rigorous quality standards. It propels our vision to become a world leader in the modern manufacture of oral nicotine, energy and nutraceutical pouches. Additionally, it strengthens our ability to serve high-volume brands in international markets.”

About TJP Labs Inc. TJP Labs is a leading full-service North American manufacturer and global contract manufacturer of premium, next-generation products specializing in modern oral nicotine, energy and nutraceuticals. Our products are manufactured and packaged in our state-of-the-art DEL facility, site licensed, GMP/HACCP compliant and ISO 9001:2015 certified.

contacts

David Richmond-Peck – [email protected]

Website: www.tjplabs.com

Copyright 2022 GlobeNewswire, Inc.

Comments are closed.